Avalyn Pharma Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AVLN | AVTX | VCRE | ARDX | INVA | GYRE | |
|---|---|---|---|---|---|---|
| Market cap | 1.10B | 710.06M | 259.96M | 833.95M | 1.55B | 727.92M |
| P/E (TTM) | — | — | — | — | 5.0 | — |
| Forward P/E | -13.1 | -4.9 | — | 11.1 | 9.7 | 114.4 |
| Price/book | 2.8 | 1.6 | — | 5.4 | 1.3 | 6.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −15.90% | −5.36% | −44.62% | −35.53% | +25.21% | −16.09% |
| Today | −3.73% | −3.00% | +2.56% | −1.52% | +1.13% | −2.49% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AVLN news ›Avalyn Pharma (NASDAQ:AVLN) Stock Price Down 5.1% - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s share price traded down 5.1% on Monday. The stock traded as low as $26.69 and last traded at $26.69. 91,164 shares changed hands during mid-day trading, a decline of 71% from the average…
Avalyn Pharma (NASDAQ:AVLN) Upgraded at Raymond James Financial
Posted by Michael Walen on Oct 5th, 2026 Raymond James Financial upgraded shares of Avalyn Pharma (NASDAQ:AVLN – Free Report) to a moderate buy rating in a research report sent to investors on Friday morning,Zacks reports. Get Our Latest…
Avalo Therapeutics (NASDAQ:AVTX) Stock Price Down 5.8% – Here’s What Happened
Posted by Kim Johansen on Oct 6th, 2026 Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report)’s share price dropped 5.8% during mid-day trading on Tuesday. The stock traded as low as $14.17 and last traded at $13.7560. Approximately…
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Has Average Target Price of $60.00
Posted by Mitch Edgeman on Oct 4th, 2026 Read Our Latest Stock Report on Avalyn Pharma AVLN opened at $28.13 on Thursday. Avalyn Pharma has a 12-month low of $24.15 and a 12-month high of $40.17. The company has a market capitalization of…
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated "Moderate Buy" by Wall Street Analysts
View Our Latest Report on Avalyn Pharma AVLN stock opened at $28.49 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 33.12 and a quick ratio of 33.12. The firm has a market capitalization of $1.26 billion and…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketbeat.com3
-
themarketsdaily.com3
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.